The proportions of patients in the anti-β2GPI/HLA-DR antibody-positive group who had autoimmune diseases, who used immunosuppressive drugs, and who were positive for aPLs were significantly higher than those in the anti-β2GPI/HLA-DR antibody-negative group. Here, APOH is linked to autoimmune disease.